NO20015227L - Fremgangsmate for a oke effektiviteten til anti-cancer midler - Google Patents

Fremgangsmate for a oke effektiviteten til anti-cancer midler

Info

Publication number
NO20015227L
NO20015227L NO20015227A NO20015227A NO20015227L NO 20015227 L NO20015227 L NO 20015227L NO 20015227 A NO20015227 A NO 20015227A NO 20015227 A NO20015227 A NO 20015227A NO 20015227 L NO20015227 L NO 20015227L
Authority
NO
Norway
Prior art keywords
effectiveness
increasing
cancer agents
cancer
agents
Prior art date
Application number
NO20015227A
Other languages
English (en)
Other versions
NO20015227D0 (no
Inventor
Steven M Piver
David Silver
Original Assignee
Health Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Research Inc filed Critical Health Research Inc
Publication of NO20015227D0 publication Critical patent/NO20015227D0/no
Publication of NO20015227L publication Critical patent/NO20015227L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • External Artificial Organs (AREA)
NO20015227A 1999-04-27 2001-10-25 Fremgangsmate for a oke effektiviteten til anti-cancer midler NO20015227L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/300,124 US6171620B1 (en) 1999-04-27 1999-04-27 Method of enhancing the efficacy of anti-tumor agents
PCT/US2000/011000 WO2000064455A1 (en) 1999-04-27 2000-04-24 Method of enhancing the efficacy of anti-tumor agents

Publications (2)

Publication Number Publication Date
NO20015227D0 NO20015227D0 (no) 2001-10-25
NO20015227L true NO20015227L (no) 2001-12-27

Family

ID=23157813

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015227A NO20015227L (no) 1999-04-27 2001-10-25 Fremgangsmate for a oke effektiviteten til anti-cancer midler

Country Status (18)

Country Link
US (3) US6171620B1 (no)
EP (1) EP1212068A4 (no)
JP (1) JP2002542296A (no)
KR (1) KR100693796B1 (no)
CN (1) CN1188137C (no)
AU (1) AU781301B2 (no)
BG (1) BG64940B1 (no)
BR (1) BR0010082A (no)
CA (1) CA2368618C (no)
HU (1) HUP0200840A3 (no)
IL (1) IL146012A0 (no)
MX (1) MXPA01010899A (no)
NO (1) NO20015227L (no)
NZ (1) NZ514521A (no)
PL (1) PL350918A1 (no)
RU (1) RU2271829C2 (no)
WO (1) WO2000064455A1 (no)
ZA (1) ZA200108012B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7678391B2 (en) * 2000-04-26 2010-03-16 Queen's University At Kingston Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
US20050142217A1 (en) * 2000-04-26 2005-06-30 Adams Michael A. Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
EP1278547B1 (en) 2000-04-26 2004-11-03 Cellegy Pharmaceuticals, Inc Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
DE60332358D1 (de) * 2002-09-09 2010-06-10 Hanall Pharmaceutical Co Ltd Protease-resistente modifizierte interferon alpha polypeptide
BRPI0409133B8 (pt) 2003-04-08 2021-05-25 Progenics Pharm Inc preparações farmacêuticas estavéis compreendendo metilnaltrexona
DE10361813A1 (de) * 2003-12-30 2005-09-08 Bionethos Holding Gmbh Verfahren zur Regeneration von Gewebe
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8524731B2 (en) 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US9662390B2 (en) * 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
AR057035A1 (es) 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
AR057325A1 (es) 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
EP2120998B1 (en) 2006-11-28 2013-08-07 HanAll Biopharma Co., Ltd. Modified erythropoietin polypeptides and uses thereof for treatment
ES2540551T3 (es) 2007-03-29 2015-07-10 Wyeth Llc Antagonistas de receptores opioides periféricos y usos de los mismos
WO2008121348A2 (en) 2007-03-29 2008-10-09 Progenics Pharmaceuticals, Inc. Peripheral opioid receptor antagonists and uses thereof
JP2010522756A (ja) 2007-03-29 2010-07-08 プロジェニックス ファーマシューティカルズ，インコーポレーテッド 結晶形およびその使用
WO2009099411A1 (en) 2008-02-06 2009-08-13 Progenics Pharmaceuticals, Inc. Preparation and use of (r),(r)-2,2'-bis-methylnaltrexone
CA2719134C (en) 2008-03-21 2015-06-30 The University Of Chicago Treatment with opioid antagonists and mtor inhibitors
WO2009140382A2 (en) * 2008-05-15 2009-11-19 Edison Pharmaceuticals, Inc. Treatment of hearing and balance impairments using compounds having erythropoietin activity
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof
PL230756B1 (pl) * 2015-09-11 2018-12-31 Univ Medyczny W Bialymstoku Erytropoetyna oraz inhibitor kinazy Brutona w postaci 2- cyjan o-N-( 2,5-dibromofenylo)- 3-hydroksy-2- butenamidu do zastosowania jako lek oraz ich zastosowanie do wytwarzania leku do terapii nowotworu
JPWO2019083023A1 (ja) * 2017-10-26 2020-11-12 国立大学法人 筑波大学 癌の治療に使用するための組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4745099A (en) * 1985-02-06 1988-05-17 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of malignant tumors
JP2632014B2 (ja) * 1988-03-03 1997-07-16 中外製薬株式会社 骨髄機能障害性貧血治療剤
JPH1067678A (ja) * 1996-06-20 1998-03-10 Chugai Pharmaceut Co Ltd 肝疾患治療用医薬組成物
US20020052309A1 (en) * 1996-09-11 2002-05-02 Athanasius A. Anagnostou Method of treating endothelial injury

Also Published As

Publication number Publication date
KR100693796B1 (ko) 2007-03-12
RU2271829C2 (ru) 2006-03-20
CN1352561A (zh) 2002-06-05
MXPA01010899A (es) 2003-06-24
US20020198153A1 (en) 2002-12-26
US6426094B2 (en) 2002-07-30
IL146012A0 (en) 2002-07-25
NZ514521A (en) 2003-07-25
US20010000730A1 (en) 2001-05-03
CA2368618A1 (en) 2000-11-02
ZA200108012B (en) 2003-03-26
HUP0200840A3 (en) 2003-04-28
EP1212068A4 (en) 2007-03-14
PL350918A1 (en) 2003-02-10
BR0010082A (pt) 2002-01-15
BG106057A (en) 2002-04-30
EP1212068A1 (en) 2002-06-12
JP2002542296A (ja) 2002-12-10
CN1188137C (zh) 2005-02-09
US6171620B1 (en) 2001-01-09
US6620779B2 (en) 2003-09-16
WO2000064455A1 (en) 2000-11-02
KR20020000557A (ko) 2002-01-05
CA2368618C (en) 2011-03-01
HUP0200840A2 (hu) 2002-07-29
NO20015227D0 (no) 2001-10-25
AU4486300A (en) 2000-11-10
BG64940B1 (bg) 2006-10-31
AU781301B2 (en) 2005-05-12

Similar Documents

Publication Publication Date Title
NO20015227L (no) Fremgangsmate for a oke effektiviteten til anti-cancer midler
NO20016169L (no) Hydraulisk setteverktöy
PT1181017E (pt) Inibidores de metaloproteases
SE9902595D0 (sv) Verktyg
DE60032892D1 (de) Schnellösemutter
PT1194404E (pt) Inibidores de aspartil-protease
DE60007050D1 (de) IMC-Verfahren
DE60016267D1 (de) Nietvorrichtung
ATE218675T1 (de) Befestigungsmittel
DE60110919D1 (de) Modulare antiseismische vorrichtung zum schutz von gebäuden
NO20014926L (no) Farmasöytiske forbindelser
DE60029393D1 (de) Bolzen
DE50010446D1 (de) Emulsionen
DE60027109D1 (de) Vorrichtung zum Eliminieren von Blasen
ITMI20001543A0 (it) Spray scintillante per biancheria
DE60014790D1 (de) Vorrichtung zum Reduzieren von Rauschen
DE69909846D1 (de) Faltschachtel
DE60002824D1 (de) System zum Entwerfen von Primern
ATE244992T1 (de) Sprühvorrichtung
DE50003324D1 (de) Pulverkraftbetriebenes Setzgerät
DE50003014D1 (de) N-substituierte perhydrodiazine
DE69921620D1 (de) Vorrichtung zum Schweissen
FI3964U1 (fi) Pylväs
ITRM990062U1 (it) Progetto x
FI4251U1 (fi) Lokasuoja

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application